Solventum Corporation SOLV

89.50 0.91 1.03% as of 25 Sep
Market cap
$15.1B
P/E
10.9×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Solventum Corporation (SOLV) Price to free cash flow

Solventum Corporation has no meaningful price to free cash flow: its trailing twelve-month free cash flow is negative. Over the past ten years it has ranged from 0.0× (September 2026) to 299× (November 2025) — the current reading is the lowest in ten years.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 0.0× —
FY2024 14.2× 67.17%
FY2023 8.5× 0.00%
FY2022 8.5× —

Quarterly

Period Price to free cash flow Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 254× 183.32%
10 more quarters

Against its own ten years

Low 0.0× High 299×
Ten-year median 9.1×
Current reading's percentile 29

Price to free cash flow against peers

Company Price to free cash flow
SOLV Solventum Corporation n/m
BAX Baxter International Inc. compare 14.8×
ALGN Align Technology, Inc. compare 15.5×
COO The Cooper Companies, Inc. compare 15.8×
ALC Alcon compare 19.7×
AVTR Avantor, Inc. compare 22.7×
ATR AptarGroup, Inc. compare 25.1×
WST West Pharmaceutical Services, Inc. compare 60.6×
RGEN Repligen Corporation compare 175×
Medical Instruments & Supplies industry median 25.7×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on SOLV